139 related articles for article (PubMed ID: 15634643)
1. Antisense oligonucleotides targeted to the human alpha folate receptor inhibit breast cancer cell growth and sensitize the cells to doxorubicin treatment.
Jhaveri MS; Rait AS; Chung KN; Trepel JB; Chang EH
Mol Cancer Ther; 2004 Dec; 3(12):1505-12. PubMed ID: 15634643
[TBL] [Abstract][Full Text] [Related]
2. Tumor-targeting, systemically delivered antisense HER-2 chemosensitizes human breast cancer xenografts irrespective of HER-2 levels.
Rait AS; Pirollo KF; Xiang L; Ulick D; Chang EH
Mol Med; 2002 Aug; 8(8):475-86. PubMed ID: 12435858
[TBL] [Abstract][Full Text] [Related]
3. Combining doxorubicin and liposomal anti-HER-2/NEU antisense oligodeoxynucleotides to treat HER-2/NEU-expressing MDA-MB-435 breast tumor model.
Waterhouse DN; Gelmon KA; Masin D; Bally MB
J Exp Ther Oncol; 2003; 3(5):261-71. PubMed ID: 14696623
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of growth of human breast carcinoma cells by an antisense oligonucleotide targeted to the transferrin receptor gene.
Yang DC; Jiang XP; Elliott RL; Head JF
Anticancer Res; 2001; 21(3B):1777-87. PubMed ID: 11497259
[TBL] [Abstract][Full Text] [Related]
5. Folate-mediated targeting of antisense oligodeoxynucleotides to ovarian cancer cells.
Li S; Deshmukh HM; Huang L
Pharm Res; 1998 Oct; 15(10):1540-5. PubMed ID: 9794495
[TBL] [Abstract][Full Text] [Related]
6. Functional aspects of membrane folate receptors in human breast cancer cells with transport-related resistance to methotrexate.
Pinard MF; Jolivet J; Ratnam M; Kathmann I; Molthoff C; Westerhof R; Schornagel JH; Jansen G
Cancer Chemother Pharmacol; 1996; 38(3):281-8. PubMed ID: 8646804
[TBL] [Abstract][Full Text] [Related]
7. Antisense Bcl-2 and HER-2 oligonucleotide treatment of breast cancer cells enhances their sensitivity to anticancer drugs.
Tanabe K; Kim R; Inoue H; Emi M; Uchida Y; Toge T
Int J Oncol; 2003 Apr; 22(4):875-81. PubMed ID: 12632082
[TBL] [Abstract][Full Text] [Related]
8. A comparative study of folate receptor-targeted doxorubicin delivery systems: dosing regimens and therapeutic index.
Scomparin A; Salmaso S; Eldar-Boock A; Ben-Shushan D; Ferber S; Tiram G; Shmeeda H; Landa-Rouben N; Leor J; Caliceti P; Gabizon A; Satchi-Fainaro R
J Control Release; 2015 Jun; 208():106-20. PubMed ID: 25869964
[TBL] [Abstract][Full Text] [Related]
9. Folate transport and the modulation of antifolate sensitivity in a methotrexate-resistant human breast cancer cell line.
Dixon KH; Trepel JB; Eng SC; Cowan KH
Cancer Commun; 1991; 3(12):357-65. PubMed ID: 16296001
[TBL] [Abstract][Full Text] [Related]
10. Antitumor effect of c-myc antisense phosphorothioate oligodeoxynucleotides on human melanoma cells in vitro and and in mice.
Leonetti C; D'Agnano I; Lozupone F; Valentini A; Geiser T; Zon G; Calabretta B; Citro G C; Zupi G
J Natl Cancer Inst; 1996 Apr; 88(7):419-29. PubMed ID: 8618233
[TBL] [Abstract][Full Text] [Related]
11. Doxorubicin loaded polymeric gold nanoparticles targeted to human folate receptor upon laser photothermal therapy potentiates chemotherapy in breast cancer cell lines.
Banu H; Sethi DK; Edgar A; Sheriff A; Rayees N; Renuka N; Faheem SM; Premkumar K; Vasanthakumar G
J Photochem Photobiol B; 2015 Aug; 149():116-28. PubMed ID: 26057021
[TBL] [Abstract][Full Text] [Related]
12. Efficient delivery of an antisense oligodeoxyribonucleotide formulated in folate receptor-targeted liposomes.
Chiu SJ; Marcucci G; Lee RJ
Anticancer Res; 2006; 26(2A):1049-56. PubMed ID: 16619505
[TBL] [Abstract][Full Text] [Related]
13. HER-2-targeted antisense oligonucleotide results in sensitization of head and neck cancer cells to chemotherapeutic agents.
Rait AS; Pirollo KF; Ulick D; Cullen K; Chang EH
Ann N Y Acad Sci; 2003 Dec; 1002():78-89. PubMed ID: 14751825
[TBL] [Abstract][Full Text] [Related]
14. Antisense ferritin oligonucleotides inhibit growth and induce apoptosis in human breast carcinoma cells.
Yang DC; Jiang X; Elliott RL; Head JF
Anticancer Res; 2002; 22(3):1513-24. PubMed ID: 12168831
[TBL] [Abstract][Full Text] [Related]
15. [Optimal effects of liposome on antisense oligodeoxynucleotides uptake by mouse breast cancer TM40D cells and the effects of antisense oligodeoxynucleotides targeting c-erbB-2 on cell proliferation and apoptosis].
Liu XA; Fan P; Wu ZY
Zhonghua Wai Ke Za Zhi; 2004 Jul; 42(13):802-5. PubMed ID: 15363300
[TBL] [Abstract][Full Text] [Related]
16. Intracellular uptake and intracavitary targeting of folate-conjugated liposomes in a mouse lymphoma model with up-regulated folate receptors.
Shmeeda H; Mak L; Tzemach D; Astrahan P; Tarshish M; Gabizon A
Mol Cancer Ther; 2006 Apr; 5(4):818-24. PubMed ID: 16648551
[TBL] [Abstract][Full Text] [Related]
17. Delivery of antisense oligodeoxyribonucleotides against the human epidermal growth factor receptor into cultured KB cells with liposomes conjugated to folate via polyethylene glycol.
Wang S; Lee RJ; Cauchon G; Gorenstein DG; Low PS
Proc Natl Acad Sci U S A; 1995 Apr; 92(8):3318-22. PubMed ID: 7724560
[TBL] [Abstract][Full Text] [Related]
18. Efficient intracellular delivery of oligonucleotides formulated in folate receptor-targeted lipid vesicles.
Zhou W; Yuan X; Wilson A; Yang L; Mokotoff M; Pitt B; Li S
Bioconjug Chem; 2002; 13(6):1220-5. PubMed ID: 12440856
[TBL] [Abstract][Full Text] [Related]
19. Resistance to methotrexate in SKOV-3 cell lines after chronic exposure to carbamazepine is associated with a decreased expression of folate receptor.
Toffoli G; Corona G; Tolusso B; Sartor F; Sorio R; Mini E; Boiocchi M
Int J Cancer; 2000 Mar; 85(5):683-90. PubMed ID: 10699949
[TBL] [Abstract][Full Text] [Related]
20. Effect of MDR1 phosphorothioate antisense oligodeoxynucleotides in multidrug-resistant human tumor cell lines and xenografts.
Ramachandran C; Wellham LL
Anticancer Res; 2003; 23(3B):2681-90. PubMed ID: 12894558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]